Decrease [qlco]    
alpha fetoprotein levels [lbtr]    
Relate [orch]    
Administration [ocac]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
High [qlco]    
Level [qlco]    
Known [qlco]    
Very high [fndg]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Type [qlco]    
Hepatitis, Chronic [dsyn]    
Cirrhosis [dsyn]    
used [fndg]    
Diagnostic Marker [clna]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Show [inpr]    
Continual [idcn]    
High [qlco]    
Values [qlco]    
Evidence [ftcn]    
Hepatocellular carcinoma [neop]    
studies [mnob]    
Defined [cnce]    
patient [podg]    
high-risk group [popg]    
Hepatocellular carcinoma [neop]    
in vitro study [resa]    
Show [inpr]    
Arrest [dsyn]    
Cell Proliferation [celf]    
Enhance [acty]    
Apoptosis [celf]    
Specific [qlco]    
Cytotoxic T lymphocyte [cell]    
Hepatocellular carcinoma [neop]    
Result [ftcn]    
Direct [qlco]    
Action [ftcn]    
studies [mnob]    
investigate [ftcn]    
Effect [qlco]    
Change [ftcn]    
Hepatitis C, Chronic [dsyn]    
patient [podg]    
/40 [tmco]    
patient [podg]    
Hepatitis C, Chronic [dsyn]    
diagnostic image [diap]    
confirm [qlco]    
absence [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Show [inpr]    
High [qlco]    
Pretreatment [sbst]    
Values [qlco]    
High [qlco]    
Group [idcn]    
alpha fetoprotein levels [lbtr]    
ng/dL [qnco]    
Mean [qnco]    
SD [fndg]    
ng/dL [qnco]    
Show [inpr]    
low [qlco]    
Pretreatment [sbst]    
Values [qlco]    
low [qlco]    
Group [idcn]    
Pretreatment [sbst]    
alpha fetoprotein levels [lbtr]    
ng/dL [qnco]    
Mean [qnco]    
SD [fndg]    
ng/dL [qnco]    
Pretreatment [sbst]    
Clinical [qlco]    
Parameter [fndg]    
Statistic [ocdi]    
Evaluable [ftcn]    
Alpha Value [qlco]    
High [qlco]    
Group [idcn]    
Platelet Count [lbpr]    
Albumin level [lbtr]    
Lower [spco]    
Suggest [idcn]    
Alpha Value [qlco]    
Increase [ftcn]    
Advance [medd]    
Liver disease [dsyn]    
patient [podg]    
Administer [ftcn]    
Group [idcn]    
Remaining [qlco]    
patient [podg]    
Administer [ftcn]    
Preparation [ftcn]    
Group [idcn]    
Control [grup]    
Group therapy [topp]    
Receive [qlco]    
Liver [bpoc]    
Reduced [qlco]    
Group [idcn]    
Mean [qnco]    
mg ml [qnco]    
23 [qnco]    
mg ml [qnco]    
Reduced [qlco]    
Group [idcn]    
Mean [qnco]    
65 [inpr]    
ng/mL [qnco]    
Significance [qnco]    
Change [ftcn]    
Group [idcn]    
Mean [qnco]    
ng/mL [qnco]    
diagnose [fndg]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Show [inpr]    
Persistence [idcn]    
High [qlco]    
alpha fetoprotein levels [lbtr]    
absence [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
described [idcn]    
high-risk group [popg]    
Hepatocellular carcinoma [neop]    
studies [mnob]    
Found [qnco]    
interferon therapy [topp]    
Not [ftcn]    
Reduced [qlco]    
baseline [bodm]    
Significance [qnco]    
Predictor [idcn]    
Hepatocellular carcinoma [neop]    
Therapeutic [topp]    
strategies [menp]    
Hepatitis C [dsyn]    
long-term treatment [hlca]    
Low dose [qnco]    
Hepatocarcinogenesis [neop]    
